Mobile App for Improving Adherence of Rivoxaban (RIVOX-AF)

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 637 participants.

Also called NCT05557123

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 637 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT05557123
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT05557123. Randomized; no masking; primary purpose treatment. Start 2022-03-10 (actual); primary completion 2025-12-16 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Mobile App for Improving Adherence of Rivoxaban (RIVOX-AF)
Intervention (Device)
MEDI-app
Lead sponsor
Seoul National University Bundang Hospital (class: other)
Collaborator
SAMJIN PHARM (class: not stated)

Record details

Record id
cardio:ct-nct05557123
Content hash
633b059a9b47710cb3f059cf7c7ad9c808d249e4e8a775c4fa01c39165954ead